Metraipolis › archive › dc_be41748dc297
Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42755691
- DOI
- 10.1161/hypertensionaha.126.27526
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T18:25:45.142Z
- SHA-256 of the archived text
60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c- Stable URL of this page
https://metraipolis.com/documento/dc_be41748dc297
How to cite
Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691 — Europe PMC (en), https://europepmc.org/article/MED/42755691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be41748dc297 (Metraipolis archive dc_be41748dc297, sha256 60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c)
BibTeX
@misc{dcbe41748dc297,
title = {Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42755691},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be41748dc297; sha256 60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755691. Agents can read the archived copy with the MCP tool read_document.